PRF1 and neoplasm: Upon binding to the target antigen expressed on tumor cells, CAR-T cells undergo activation, leading to the secretion of cytotoxic molecules such as perforin and granzyme, as well as the release of pro-inflammatory cytokines such as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α).